These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 723780)

  • 21. Evaluation of VITEK MS, Clin-ToF-II MS, Autof MS 1000 and VITEK 2 ANC card for identification of Bacteroides fragilis group isolates and antimicrobial susceptibilities of these isolates in a Chinese university hospital.
    Wang Y; Chen XF; Xie XL; Xiao M; Yang Y; Zhang G; Zhang JJ; Duan SM; Zhang Q; Zhang P; Tsui C; Xu YC
    J Microbiol Immunol Infect; 2019 Jun; 52(3):456-464. PubMed ID: 30772212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)].
    Tytgat F
    Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survey of antimicrobial susceptibility patterns of the bacteria of the Bacteroides fragilis group isolated from the intestinal tract of children.
    Nakano V; Avila-Campos MJ
    Mem Inst Oswaldo Cruz; 2004 May; 99(3):319-24. PubMed ID: 15273807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new chromogenic medium for isolation of Bacteroides fragilis suitable for screening for strains with antimicrobial resistance.
    Tierney D; Copsey SD; Morris T; Perry JD
    Anaerobe; 2016 Jun; 39():168-72. PubMed ID: 27060277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.
    Betriu C; Campos E; Cabronero C; Rodriguez-Avial C; Picazo JJ
    Antimicrob Agents Chemother; 1990 Apr; 34(4):671-3. PubMed ID: 2344174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology and antimicrobial resistance of B. fragilis group organisms isolated from clinical specimen and human intestinal microbiota.
    de Carvalho CB; Moreira JL; Ferreira MC
    Rev Inst Med Trop Sao Paulo; 1996; 38(5):329-35. PubMed ID: 9293074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of resistance in Bacteroides fragilis strains according to recent Brazilian profiles of antimicrobial susceptibility.
    Paula GR; Falcão LS; Antunes EN; Avelar KE; Reis FN; Maluhy MA; Ferreira MC; Domingues RM
    Int J Antimicrob Agents; 2004 Jul; 24(1):53-8. PubMed ID: 15225862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of cefotaxime alone and in combination with desacetylcefotaxime against Bacteroides fragilis.
    Wasilauskas BL
    Diagn Microbiol Infect Dis; 1989; 12(1):39-43. PubMed ID: 2714071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital.
    Yim J; Lee Y; Kim M; Seo YH; Kim WH; Yong D; Jeong SH; Lee K; Chong Y
    Ann Lab Med; 2015 Jan; 35(1):94-8. PubMed ID: 25553287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic sensitivity of the Bacteroides fragilis group in Denmark. Danish Study Group.
    Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
    APMIS; 1993 Sep; 101(9):727-31. PubMed ID: 8240792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro susceptibilities of the Bacteroides fragilis group species: change in isolation rates significantly affects overall susceptibility data.
    Aldridge KE; O'Brien M
    J Clin Microbiol; 2002 Nov; 40(11):4349-52. PubMed ID: 12409429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology, antimicrobial susceptibility, pathogenicity, and significance of Bacteroides fragilis group organisms isolated at Los Angeles County-University of Southern California Medical Center.
    Appleman MD; Heseltine PN; Cherubin CE
    Rev Infect Dis; 1991; 13(1):12-8. PubMed ID: 2017610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The microdilution antibiotic susceptibility test. Bacteroides fragilis.
    Steingrimsson O; Ryan RW; Tilton RC
    Am J Clin Pathol; 1976 Jun; 65(6):1010-5. PubMed ID: 1047602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance profile of Bacteroides fragilis isolated in Brazil. Do they shelter the cfiA gene?
    das Graças Silva E Souza W; Avelar KE; Antunes LC; Lobo LA; Domingues RM; de Souza Ferreira MC
    J Antimicrob Chemother; 2000 Apr; 45(4):475-81. PubMed ID: 10747824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987.
    Cornick NA; Cuchural GJ; Snydman DR; Jacobus NV; Iannini P; Hill G; Cleary T; O'Keefe JP; Pierson C; Finegold SM
    J Antimicrob Chemother; 1990 Jun; 25(6):1011-9. PubMed ID: 2370237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic susceptibility profiles of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan from 1990 to 1992.
    Tanaka-Bandoh K; Kato N; Watanabe K; Ueno K
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S352-5. PubMed ID: 7548596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in-vitro activity of Sch 34343 and other antimicrobial agents against anaerobic bacteria.
    Nord CE; Olsson-Liljequist B
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():183-8. PubMed ID: 2863246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Timed bacteriostatic and bactericidal activities of selected antimicrobial agents against Bacteroides fragilis isolated from clinical specimens.
    Masuda G
    J Antibiot (Tokyo); 1984 Apr; 37(4):401-7. PubMed ID: 6725144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989.
    Cuchural GJ; Snydman DR; McDermott L; Iannini PB; Hill GB; Cleary TJ; O'Keefe JP; Pierson CL; Rihs JD; Finegold SM
    Clin Ther; 1992; 14(1):122-36. PubMed ID: 1576621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.